|About the Book|
Endometriosis is a common, chronic, inflammatory and estrogen-dependent gynecological disease that develops from a combination of genetic predisposition and environmental factors. It affects 10 to 15% of women in their reproductive years [Giudice LC,MoreEndometriosis is a common, chronic, inflammatory and estrogen-dependent gynecological disease that develops from a combination of genetic predisposition and environmental factors. It affects 10 to 15% of women in their reproductive years [Giudice LC, Kao LC.Endometriosis.Lancet. 2004 Nov 13-19- 364(9447):1789-99.]Endometriosis affects an estimated 176 million women worldwide.Current estimates suggest that approximately 5 million women in the United States are affected with endometriosis. Endometriosis accounts for $22 billion annually in total US healthcare costs.In fact, no symptoms of endometriosis may actually appear initially. If this finding applies to all the women in the United States, the number of American women with endometriosis may well exceed previous estimates of 5 million.Endometriosis is most common in women in their 30s and 40s [American College of Obstetricians and Gynecologists. (2010). Management of endometriosis (Practice Bulletin No. 114). Obstetrics & Gynecology, 116(1), 223-236] but it can affect any female who menstruates.This e-Book is an attempt to explain the cutting edge of endometriosis prevalence and risk factors, and symptoms and diagnosis as well as treatment options available. The book incorporates the first-ever worldwide consensus statement on the management of endometriosis issued by The World Endometriosis Society (WES) Montpellier Consortium—an international group of 56 individuals representing women with endometriosis and representatives from 34 medical and non-medical organizations, including the National Institute of Child Health and Human Development (NICHD).